ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626167 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626167; 2) Community: the network communities that were significantly associated with the response to NSC 626167; 3) Molecule: the relationships between components within communities and NSC 626167; 4) MDR: the compounds that were significantly associated with the NSC 626167.

NSC Compound Enrichment Correlation
NSC 107124 Camptothecin Derivative 0.0162638908166157 0.12248252
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0162638908166157 0.15611705
NSC 264880 Dihydro-5-azacytidine 0.0162638908166157 0.11371306
NSC 49488 Null 0.0162638908166157 0.32336077
NSC 57958 Null 0.0162638908166157 0.093292379
NSC 605607 Null 0.0162638908166157 0.41697104
NSC 622070 Null 0.0162638908166157 0.42753784
NSC 628559 Null 0.0162638908166157 0.17797753
NSC 628560 Null 0.0162638908166157 0.27975821
NSC 629749 .beta.-Lapachone 0.0162638908166157 0.20028967
Total:87  Current:34    [First] [Prev] [Next] [Last]